Max Ventures and Industries’ wholly owned subsidiary — Max Estates has completed acquisition of 85.17% equity share capital of Pharmax on November 25, 2019 for an aggregate consideration of Rs 60.73 crore, in terms of the Share Purchase Agreement executed amongst Max Estates, Max India, and Pharmax. Consequent to the completion of the acquisition, Pharmax has become a step down subsidiary of the company, through Max Estates.
Max Ventures and Industries, a part of the $3 billion Max Group, operates primarily in the areas of manufacturing and real estate.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.